WNT10B and endometrial carcinoma: By immunohistochemistry of the proliferative phase, secretory phase, simple hyperplasia, complex hyperplasia, atypical hyperplasia, and endometrial carcinoma tissues, WNT10B had increased expression in the cancerous endometrial carcinoma samples.